Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account
A A A

Jupiter China Fund - management change update

Kate Marshall | Tue 02 June 2015

Investments can go down as well as up so there is always a danger that you could get back less than you invest. Nothing here is personalised advice, if unsure you should seek advice.

Ross Teverson took over management of the Jupiter China Fund from Philip Ehrmann on 1 January 2015. I recently met the new manager to find out more about his strategy and the changes made to the fund so far.

Ross Teverson believes most value can be added by taking a truly benchmark-agnostic investment approach, meaning he pays little attention to the positioning of the fund's benchmark when constructing the portfolio. In light of this, the manager will also look to run a more concentrated portfolio of around 40 holdings, compared with approximately 50-60 stocks under the previous manager. This means each stock will have a greater impact on returns, although it is a higher-risk approach.

The manager tends to focus on individual company analysis, rather than taking a wider view on the economic environment. This differs from the previous manager's strategy who adopted a more thematic approach; positioning the fund towards industries he believed would drive future growth in China. Ross Teverson does, however, expect the fund will maintain its bias towards higher-risk medium-sized companies. In his view, looking across the entire market for the best opportunities will naturally lead to investments in smaller, as well as larger, firms.

Change is the core focus of Ross Teverson's overriding philosophy. In his view, material changes that drive share prices can occur at a structural level, an industry level and at the company level. He seeks insights into how corporate prospects are changing for the better, which he believes is not taken into account by other investors. Once recognised, a company's share price could rebound.

In an effort to reduce the fund's similarity with its benchmark, exposure to the financials sector, which makes up a considerable portion of the benchmark index, has been reduced. Ross Teverson has focused on selling low-conviction holdings, or companies he does not feel are undergoing significant change. Two brokerage firms, Citic Securities and Haitong, have been sold, while exposure to Chinese banks has also been reduced.

Register for free fund research by email

Our view on this fund

On the whole we like Ross Teverson's unconstrained and concentrated investment approach, with a primary focus on stock selection. We also view it positively that he will maintain the fund's bias to medium-sized companies, which could prove a source of value over the long term, while it also differentiates the fund from many of its peers focused on larger businesses.

At this time the fund will not be added to the Wealth 150 list of our favourite funds across the major sectors. Ross Teverson has prior experience managing Chinese equities as part of a broader emerging markets portfolio; however, he does not have experience managing a more specialist, single country fund. As such we would like to see him build a longer track record before taking a view on his abilities in managing this fund.

Find out more about this fund including how to invest

Please read the key features/key investor information document in addition to the information above.

The value of investments can go down as well as up, this means you could get back less than you invested. Therefore all investments should be regarded with a long term view. No news or research item is a personal recommendation to deal. If you are unsure about the suitability of an investment please contact us for advice.
Important information - Please remember the value of investments, and any income from them, can fall as well as rise so you could get back less than you invest. This article is provided to help you make your own investment decisions, it is not advice. If you are unsure of the suitability of an investment for your circumstances please seek advice. No news or research item is a personal recommendation to deal.


You may also be interested in: